Not applicableLooking for participantsNCT06546267What this trial is testingAdvanced Radiotherapy (ART) in Prostate Cancer (PROST-ART)Who this might be right forProstate Cancer IRCCS San Raffaele 2,500
Large-scale testing (Phase 3)Study completedNCT00134056What this trial is testingS0421, Docetaxel and Prednisone With or Without Atrasentan in Treating Patients With Stage IV Prostate Cancer and Bone Metastases That Did Not Respond to Previous Hormone TherapyWho this might be right forMetastatic CancerProstate Cancer SWOG Cancer Research Network 1,038
Not applicableEnded earlyNCT00918645What this trial is testingCalcium-41 (41Ca) Chloride Aqueous Solution in Diagnosing Patients With Prostate Cancer and Bone MetastasisWho this might be right forMetastatic CancerProstate Cancer University of California, Davis 13
Testing effectiveness (Phase 2)Looking for participantsNCT06139575What this trial is testingPhase 1/2 Clinical Study of Lutetium Lu 177 JH020002 Injection in Patients With Advanced Prostate CancerWho this might be right forProstate Cancer Bivision Pharmaceuticals, Inc. 90
Testing effectiveness (Phase 2)Study completedNCT00171912What this trial is testingImatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase EnzymesWho this might be right forHypereosinophilic SyndromeSystemic MastocytosisChronic Myelomonocytic Leukemia+1 more Novartis Pharmaceuticals 38
Not applicableActive Not RecruitingNCT03017794What this trial is testingEvaluation of Neuroendocrine Differentiation as a Potential Mechanism of Tumor Recurrence Following RadiotherapyWho this might be right forProstate Cancer Mayo Clinic 118
Post-approval studies (Phase 4)Study completedNCT01977651What this trial is testingEvaluate the Potential Increased Risk of Seizures Among Metastatic Castration-Resistant Prostate Cancer (mCRPC) Patients Treated With EnzalutamideWho this might be right forMetastatic Castration-resistant Prostate Cancer (mCRPC) Astellas Pharma Global Development, Inc. 424
Not applicableAvailableNCT04091295What this trial is testingBLESSED: Expanded Access for DNG64-CAR-V for Advanced Pancreatic Cancer, Sarcoma and Carcinoma of BreastWho this might be right forPancreatic CancerOsteosarcomaMPNST (Malignant Peripheral Nerve Sheath Tumor)+6 more Aveni Foundation
Not applicableStudy completedNCT05079828What this trial is testingHead-to-head Comparison of 68Ga-PSMA-11 and 18F-PSMA-1007Who this might be right forProstate Cancer Insel Gruppe AG, University Hospital Bern 100
Not applicableActive Not RecruitingNCT04788277What this trial is testingInvestigation Into Detection of Prostate Cancer Using Voided Urine (Prostate VPAC)Who this might be right forProstate Carcinoma Thomas Jefferson University 810
Testing effectiveness (Phase 2)Study completedNCT00083005What this trial is testingDocetaxel, Estramustine, and Thalidomide in Treating Patients With Androgen-Independent Metastatic Adenocarcinoma of the ProstateWho this might be right forProstate Cancer National Institutes of Health Clinical Center (CC) 60
Not applicableStudy completedNCT00869739What this trial is testingHelping African American Prostate Cancer Survivors and Their Partners Cope With Challenges After Surgery for Prostate CancerWho this might be right forCancer SurvivorDepressionGastrointestinal Complications+4 more East Carolina University 112
Not applicableStudy completedNCT03702439What this trial is testingProstate Cancer Screening Trial Using ImagingWho this might be right forProstate Neoplasm Imperial College London 411
Not applicableStudy completedNCT00582530What this trial is testingMen Undergoing Radical ProstatectomyWho this might be right forProstate Cancer Memorial Sloan Kettering Cancer Center 513
Early research (Phase 1)UnknownNCT00625430What this trial is testingA Phase I Gene Therapy Study of FP253/Fludarabine for Prostate CancerWho this might be right forProstate Cancer Biotech Equity Partners Pty Ltd 18
Not applicableStudy completedNCT01780701What this trial is testingMagnetic Resonance Spectroscopic Imaging Study of Prostatic Fats to Distinguish the Difference Between High and Low Risk Prostate CancerWho this might be right forProstate Cancer OHSU Knight Cancer Institute 66
Testing effectiveness (Phase 2)Study completedNCT01251861What this trial is testingBicalutamide With or Without Akt Inhibitor MK2206 in Treating Patients With Previously Treated Prostate CancerWho this might be right forRecurrent Prostate CarcinomaStage I Prostate Cancer AJCC v7Stage IIA Prostate Cancer AJCC v7+2 more National Cancer Institute (NCI) 108
Early research (Phase 1)Study completedNCT03310541What this trial is testingAZD5363 in Patients With Advanced Solid Tumors Harboring AKT MutationsWho this might be right forBreast CancerProstate CancerAdvanced Solid Tumors Memorial Sloan Kettering Cancer Center 12
Testing effectiveness (Phase 2)Study completedNCT00751205What this trial is testingPrevention of Sagopilone-induced Neurotoxicity With Acetyl-L-Carnitine (ALC)Who this might be right forProstate CancerOvarian Cancer Bayer 150
Post-approval studies (Phase 4)Study completedNCT00334139What this trial is testingEffect of Zoledronic Acid on Bone Metabolism in Patients With Bone Metastasis and Prostate or Breast CancerWho this might be right forProstate CancerBreast CancerBone Metastasis Novartis Pharmaceuticals 411